Esther Raskopf (E Raskopf)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Patient Reported

Placebo Controlled

Allergic Rhinitis

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Ralph Mosges, Christoph Zeyen, Esther Raskopf, Cengizhan Acikel, Hacer Sahin, Silke Allekotte, Mandy Cuevas, M H Mohamed Shamji, José Luis Subiza, Miguel Casanovas
A randomized, double-blind, placebo-controlled trial with mannan-conjugated birch pollen allergoids. Allergy (2023)
Van-Anh Dao, Cengizhan Acikel, Kija Shah-Hosseini, Julia Vent, Esther Raskopf, Ralph Mosges
Inadequate knowledge of allergen immunotherapy among athletes with allergic rhinitis: A post hoc analysis. Allergy 74 (12) (2019)
J-P Liedtke, A Mandl, J Köther, J Chwieralski, Kija Shah-Hosseini, Esther Raskopf, U Pieper-Fürst, S Allekotte, Ralph Mosges
RCAT reflects symptom control and quality of life in allergic rhinoconjunctivitis patients. Allergy 73 (5) (2017)
R Mösges, E M Kasche, Esther Raskopf, J Singh, L Sohlich, A Astvatsatourov, K Shah-Hosseini, S Pirotton, L Haazen, S R Durham, T Legon, G Zadoyan, M H Mohamed Shamji
A randomized, double-blind, placebo-controlled, dose-finding trial with Lolium perenne peptide immunotherapy. Allergy 73 (4) (2017)